214 related articles for article (PubMed ID: 31607752)
1. Shikonin attenuates hyperhomocysteinemia-induced CD4
Lü SL; Dang GH; Deng JC; Liu HY; Liu B; Yang J; Ma XL; Miao YT; Jiang CT; Xu QB; Wang X; Feng J
Acta Pharmacol Sin; 2020 Jan; 41(1):47-55. PubMed ID: 31607752
[TBL] [Abstract][Full Text] [Related]
2. PKM2-dependent metabolic reprogramming in CD4
Lü S; Deng J; Liu H; Liu B; Yang J; Miao Y; Li J; Wang N; Jiang C; Xu Q; Wang X; Feng J
J Mol Med (Berl); 2018 Jun; 96(6):585-600. PubMed ID: 29732501
[TBL] [Abstract][Full Text] [Related]
3. Activation of NLRP3 inflammasomes contributes to hyperhomocysteinemia-aggravated inflammation and atherosclerosis in apoE-deficient mice.
Wang R; Wang Y; Mu N; Lou X; Li W; Chen Y; Fan D; Tan H
Lab Invest; 2017 Aug; 97(8):922-934. PubMed ID: 28394319
[TBL] [Abstract][Full Text] [Related]
4. GSNOR modulates hyperhomocysteinemia-induced T cell activation and atherosclerosis by switching Akt S-nitrosylation to phosphorylation.
Li J; Zhang Y; Zhang Y; Lü S; Miao Y; Yang J; Huang S; Ma X; Han L; Deng J; Fan F; Liu B; Huo Y; Xu Q; Chen C; Wang X; Feng J
Redox Biol; 2018 Jul; 17():386-399. PubMed ID: 29860106
[TBL] [Abstract][Full Text] [Related]
5. Regulatory T cells ameliorate hyperhomocysteinaemia-accelerated atherosclerosis in apoE-/- mice.
Feng J; Zhang Z; Kong W; Liu B; Xu Q; Wang X
Cardiovasc Res; 2009 Oct; 84(1):155-63. PubMed ID: 19502284
[TBL] [Abstract][Full Text] [Related]
6. Homocysteine Activates B Cells via Regulating PKM2-Dependent Metabolic Reprogramming.
Deng J; Lü S; Liu H; Liu B; Jiang C; Xu Q; Feng J; Wang X
J Immunol; 2017 Jan; 198(1):170-183. PubMed ID: 27903739
[TBL] [Abstract][Full Text] [Related]
7. CTLA4-IgG ameliorates homocysteine-accelerated atherosclerosis by inhibiting T-cell overactivation in apoE(-/-) mice.
Ma K; Lv S; Liu B; Liu Z; Luo Y; Kong W; Xu Q; Feng J; Wang X
Cardiovasc Res; 2013 Feb; 97(2):349-59. PubMed ID: 23118130
[TBL] [Abstract][Full Text] [Related]
8. PKM2-dependent glycolysis promotes the proliferation and migration of vascular smooth muscle cells during atherosclerosis.
Zhao X; Tan F; Cao X; Cao Z; Li B; Shen Z; Tian Y
Acta Biochim Biophys Sin (Shanghai); 2020 Jan; 52(1):9-17. PubMed ID: 31867609
[TBL] [Abstract][Full Text] [Related]
9. Poly (ADP-Ribose) polymerase inhibition attenuates atherosclerotic plaque development in ApoE-/- mice with hyperhomocysteinemia.
Xie JJ; Yu X; Liao YH; Chen J; Yao R; Chen Y; Liao MY; Ding YJ; Tang TT; Cheng X
J Atheroscler Thromb; 2009 Oct; 16(5):641-53. PubMed ID: 19776495
[TBL] [Abstract][Full Text] [Related]
10. Hyperhomocysteinemia promotes inflammatory monocyte generation and accelerates atherosclerosis in transgenic cystathionine beta-synthase-deficient mice.
Zhang D; Jiang X; Fang P; Yan Y; Song J; Gupta S; Schafer AI; Durante W; Kruger WD; Yang X; Wang H
Circulation; 2009 Nov; 120(19):1893-902. PubMed ID: 19858416
[TBL] [Abstract][Full Text] [Related]
11. Overexpressed PKM2 promotes macrophage phagocytosis and atherosclerosis.
Gai X; Liu F; Wu Y; Zhang B; Tang B; Shang K; Wang L; Zhang H; Chen Y; Yang S; Deng W; Li P; Wang J; Zhang H
Animal Model Exp Med; 2023 Apr; 6(2):92-102. PubMed ID: 35974691
[TBL] [Abstract][Full Text] [Related]
12. Severe hyperhomocysteinemia promotes bone marrow-derived and resident inflammatory monocyte differentiation and atherosclerosis in LDLr/CBS-deficient mice.
Zhang D; Fang P; Jiang X; Nelson J; Moore JK; Kruger WD; Berretta RM; Houser SR; Yang X; Wang H
Circ Res; 2012 Jun; 111(1):37-49. PubMed ID: 22628578
[TBL] [Abstract][Full Text] [Related]
13. Hyperhomocysteinemia potentiates hyperglycemia-induced inflammatory monocyte differentiation and atherosclerosis.
Fang P; Zhang D; Cheng Z; Yan C; Jiang X; Kruger WD; Meng S; Arning E; Bottiglieri T; Choi ET; Han Y; Yang XF; Wang H
Diabetes; 2014 Dec; 63(12):4275-90. PubMed ID: 25008174
[TBL] [Abstract][Full Text] [Related]
14. Role of redox factor-1 in hyperhomocysteinemia-accelerated atherosclerosis.
Dai J; Li W; Chang L; Zhang Z; Tang C; Wang N; Zhu Y; Wang X
Free Radic Biol Med; 2006 Nov; 41(10):1566-77. PubMed ID: 17045925
[TBL] [Abstract][Full Text] [Related]
15. Macrophage inflammasome mediates hyperhomocysteinemia-aggravated abdominal aortic aneurysm.
Sun W; Pang Y; Liu Z; Sun L; Liu B; Xu M; Dong Y; Feng J; Jiang C; Kong W; Wang X
J Mol Cell Cardiol; 2015 Apr; 81():96-106. PubMed ID: 25680906
[TBL] [Abstract][Full Text] [Related]
16. Effects of vitamin supplementation and hyperhomocysteinemia on atherosclerosis in apoE-deficient mice.
Zhou J; Møller J; Ritskes-Hoitinga M; Larsen ML; Austin RC; Falk E
Atherosclerosis; 2003 Jun; 168(2):255-62. PubMed ID: 12801608
[TBL] [Abstract][Full Text] [Related]
17. Targeted Therapy of Atherosclerosis by a Broad-Spectrum Reactive Oxygen Species Scavenging Nanoparticle with Intrinsic Anti-inflammatory Activity.
Wang Y; Li L; Zhao W; Dou Y; An H; Tao H; Xu X; Jia Y; Lu S; Zhang J; Hu H
ACS Nano; 2018 Sep; 12(9):8943-8960. PubMed ID: 30114351
[TBL] [Abstract][Full Text] [Related]
18. WIN55212-2 ameliorates atherosclerosis associated with suppression of pro-inflammatory responses in ApoE-knockout mice.
Zhao Y; Liu Y; Zhang W; Xue J; Wu YZ; Xu W; Liang X; Chen T; Kishimoto C; Yuan Z
Eur J Pharmacol; 2010 Dec; 649(1-3):285-92. PubMed ID: 20868672
[TBL] [Abstract][Full Text] [Related]
19. Hydrogen sulfide lowers hyperhomocysteinemia dependent on cystathionine γ lyase S-sulfhydration in ApoE-knockout atherosclerotic mice.
Fan J; Zheng F; Li S; Cui C; Jiang S; Zhang J; Cai J; Cui Q; Yang J; Tang X; Xu G; Geng B
Br J Pharmacol; 2019 Sep; 176(17):3180-3192. PubMed ID: 31140595
[TBL] [Abstract][Full Text] [Related]
20. Effect of S-aspirin, a novel hydrogen-sulfide-releasing aspirin (ACS14), on atherosclerosis in apoE-deficient mice.
Zhang H; Guo C; Zhang A; Fan Y; Gu T; Wu D; Sparatore A; Wang C
Eur J Pharmacol; 2012 Dec; 697(1-3):106-16. PubMed ID: 23085268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
